CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.
Executive compensation
Form 990 · Schedule J · 1 reported individual · Filing year 2024
| Position | Total |
|---|---|
Director Officer (Unspecified) | $120k $130k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 17 unpaid individuals.
Held steady
from 2023
From $120k in 2023 to $120k in 2024.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Revenue and expenses over time
CANCER RESEARCH AND TREATMENT FUND INC reported revenue and expenses across 2 filing years.
Common questions about CANCER RESEARCH AND TREATMENT FUND INC
What are CANCER RESEARCH AND TREATMENT FUND INC's revenue and expenses?
In 2024, CANCER RESEARCH AND TREATMENT FUND INC reported $1.1M in total revenue and $1M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.